Furthermore, a targeted binding site between miR-653 and zinc finger E-box binding homeobox 2 (ZEB2) has also been validated, and hsa-circ-0004771 is reported to modulate the miR-653/ZEB2 axis to promote breast cancer progression [25]. Here, ZEB2 is linked to breast carcinoma.